DOI Services Persistent Identifiers for Scholarly Research
You are viewing the preserved copy. Open the article on the journal's website →

International Journal Of Clinical Pharmacology And Medical Sciences • pp. 1-12

PHARMACOGENOMICS AND ITS ROLE IN PERSONALIZED MEDICINE DEVELOPMENT

  • Muhammad Ahmad BS Computer Science, Department Of Computer Science, University of Okara

Abstract

Pharmacogenomics has become an important field of modern clinical pharmacology because it examines how

genetic variations influence individual responses to pharmaceutical treatments. It provides a scientific foundation

for personalized medicine by helping healthcare professionals understand why patients may respond differently to

the same medication. Traditional treatment approaches generally depend on standardized prescribing practices,

which may not always produce equally effective results because individuals possess different genetic characteristics,

metabolic activities, and biological responses. Pharmacogenomics addresses these differences by examining genes

associated with drug metabolism, transportation, and receptor activity. Recent developments in genetic sequencing,

molecular diagnostics, and pharmacogenomic testing have created new opportunities for improving medication

selection, optimizing drug dosages, and reducing preventable adverse drug reactions. This research examines the

role of pharmacogenomics in personalized medicine development, with particular attention to its contribution to

individualized treatment, medication safety, and therapeutic effectiveness. It also investigates the applications of

genetic testing in modern clinical practice and evaluates the scientific, technological, ethical, and financial

challenges associated with its implementation. The study adopts a qualitative research methodology based on

secondary academic literature and previously published scientific investigations. The findings indicate that

pharmacogenomic information can support more informed prescribing decisions by identifying genetic variations

associated with different medication responses. Furthermore, integrating genetic information into clinical practice

may improve treatment planning and strengthen patient-centered healthcare. However, limited access to genetic

testing, high implementation costs, insufficient professional training, and concerns about genetic privacy remain

significant challenges. The research concludes that pharmacogenomics represents an important foundation for

advancing personalized medicine and developing safer, more effective, and individualized pharmacological

treatments.

Record

Identifier
https://doi-services.com/1141/233
Published
2026-11-08
Version
1
Original
https://studentsconsultancyhome.com/season-2/journal/index.php/IJCPMS/article/view/233